MVP promotes hepatocellular carcinoma via targeting IRF2 and decreasing p53 activity.
暂无分享，去创建一个
E. Wiemer | Ying Zhu | Yi Yu | Mengji Lu | Mengqi Li | Fubing Wang | Li Zhou | M. Trilling | Haisheng Yu | Shi Liu | Dan Liu | R. Broering | N. Peng | Qiming Wang | Aidong Chen | Rui He | Peining Fang | Yi Zhang